USD 273.91 million
Global Pet Cancer Therapeutics Market Size, Share, Growth Analysis, By Therapy(Chemotherapy, Radiation therapy), By Animal(Dogs, Cats), By Application(Lymphoma, Mast Cell Cancer) - Industry Forecast 2024-2031
Report ID:
SQMIG35I2256 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
95 |
Figures:
75
Global Pet Cancer Therapeutics Market Insights
Global Pet Cancer Therapeutics Market size was valued at USD 273.91 million in 2022 and is poised to grow from USD 302.40 million in 2023 to USD 667.31 million by 2031, growing at a CAGR of 10.4% during the forecast period (2024-2031).
The global pet cancer therapeutics market is witnessing a notable surge in attention and innovation within the broader pet healthcare sector. As pet owners increasingly prioritize the well-being of their animal companions, the demand for effective cancer treatment options for pets has grown. This trend is driven by a growing awareness of pet health and the desire to provide pets with the best possible care.
Market players are responding with the development of new therapeutics tailored to pets, offering hope for improved outcomes and quality of life for animals diagnosed with cancer.
Additionally, advancements in veterinary oncology are contributing to a more comprehensive understanding of cancer in pets, enabling the development of targeted therapies.
The pet cancer therapeutics market presents an evolving landscape where compassion and scientific progress intersect to address the unique healthcare needs of beloved animal companions.
US Pet Cancer Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Dogs
Fastest Growth
Dogs
Growth Rate
10.4% CAGR
Global Pet cancer therapeutics market ($ Bn)
Country Share for NORTH AMERICA Region (%)
Global Pet cancer therapeutics market by animal ($ Bn)
Global Pet cancer therapeutics market by animal (%)
To get more reports on the above market click here to Buy The Report
Global Pet Cancer Therapeutics Market Segmental Analysis
The global pet cancer therapeutics market is segmented into four segments therapy, animal, application and region. Based on therapy the market is segmented as, chemotherapy, radiation therapy, immunotherapy, targeted therapy, and other therapies. Based on animal, the market is bifurcated as, dogs, cats, other animals. On the basis of application the market is segmented as, lymphoma, mast cell cancer, melanoma, mammary, and squamous cell cancer, other applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Pet Cancer Therapeutics Market Analysis by Animal
Among cats, dogs, and other animals, dogs hold the dominating position in the global pet cancer therapeutics market. This is due to the reason that Dogs are more commonly diagnosed with cancer than cats and other pets, making up a larger portion of the pet cancer patient population. Additionally, the willingness of dog owners to seek and invest in cancer treatment for their beloved pets is relatively higher compared to owners of other animals. Dogs also share more genetic similarities with humans than cats, which has led to greater research and development efforts in canine cancer therapies, further bolstering the market.
However, cats are positioned as the fastest-growing segment. This can be due to the reason that cats have a longer life expectancy than many other pets, which increases their susceptibility to age-related diseases like cancer. Moreover, the feline population has been steadily growing worldwide, contributing to a larger pool of potential patients. Additionally, advancements in feline healthcare and diagnostics are making it easier to detect and treat cancer in cats, leading to increased demand for specialized therapeutics.
Pet Cancer Therapeutics Market Analysis by Application
Lymphoma holds the largest and dominating position among the listed applications in the global pet cancer therapeutics market. This prominence can be attributed to several factors. Lymphoma is one of the most common types of cancer in pets, affecting both dogs and cats, and it often responds well to various treatment options. Additionally, advancements in veterinary oncology have led to the development of effective therapies, including chemotherapy protocols specifically designed for lymphoma in pets. The relatively higher success rates and the prevalence of this type of cancer contribute to its dominant position within the market.
Moreover, Melanoma holds the fastest-growing position. This can be attributed to several factors. Melanoma is a type of skin cancer that affects both dogs and cats, and it has been on the rise in recent years. Pet owners are becoming more vigilant about their pets' skin health, leading to increased early detection and treatment. Additionally, advancements in veterinary oncology have resulted in more effective and targeted therapies for melanoma in pets. The demand for specialized treatments for this condition is driving growth in the melanoma segment of the pet cancer therapeutics market.
Global Pet cancer therapeutics market by Animal, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Pet Cancer Therapeutics Market Regional Insights
North America was the largest and dominating region in the global pet cancer therapeutics market. This dominance can be attributed to several factors. North America has a well-established and mature pet healthcare industry, with a high level of awareness and expenditure on pet health. Moreover, the region is home to a significant number of veterinary clinics and hospitals specializing in oncology, which drives the demand for pet cancer therapeutics. Additionally, the region's pet insurance penetration also plays a role in encouraging pet owners to seek comprehensive cancer treatment options.
However, the Asia-Pacific region is emerging as the fastest-growing market for pet cancer therapeutics. This growth can be attributed to several factors. There is a rising pet ownership culture in countries across Asia-Pacific, including China and India, where the middle class is expanding, and disposable income is increasing. As pet owners in the region become more concerned about the health and well-being of their pets, the demand for advanced cancer treatment options for animals is on the rise. Moreover, the increasing awareness of pet health and the availability of specialized veterinary care are contributing to the growth of the pet healthcare sector, including cancer therapeutics.
Global Pet cancer therapeutics market by Geography, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Pet Cancer Therapeutics Market Dynamics
Pet Cancer Therapeutics Market Drivers
Rising Pet Ownership and Humanization
- A major driver in the global pet cancer therapeutics market is the increasing trend of pet humanization. As more pet owners view their animals as integral members of their families, the willingness to invest in advanced healthcare, including cancer treatments, has surged. This humanization trend translates into a higher demand for effective and compassionate cancer therapeutics tailored to pets, propelling innovation, and growth in the market.
Pet Cancer Therapeutics Market Restraints
High Treatment Costs
- One significant restraint in the global pet cancer therapeutics market is the high cost associated with cancer treatments for pets. The expenses related to diagnostics, surgeries, radiation therapy, and medication can be substantial, placing a financial burden on pet owners. This cost factor can limit the accessibility of advanced cancer treatments for many pet owners, potentially leading to difficult decisions about the level of care they can afford for their pets. As a result, despite the increasing awareness and demand for pet cancer therapeutics, affordability remains a critical issue, impacting market dynamics and the reach of these treatments.
Request Free Customization of this report to help us to meet your business objectives.
Global Pet Cancer Therapeutics Market Competitive Landscape
The competitive landscape of the global pet cancer therapeutics market is marked by a blend of innovation and collaboration among various industry participants. Emerging biotechnology firms and pharmaceutical companies are actively engaged in research and development efforts to bring novel cancer treatment options for pets to the market.
Additionally, veterinary clinics and hospitals play an essential role by providing access to these therapies and treatments. The industry is further enriched by partnerships between veterinary healthcare providers and pharmaceutical manufacturers to enhance the availability and distribution of pet cancer therapeutics.
As pet owners increasingly seek effective solutions for their beloved animal companions, competition in this sector is driven not only by product efficacy but also by a commitment to improving the quality of life for pets facing cancer diagnoses.
Pet Cancer Therapeutics Market Top Player’s Company Profiles
- Aratana Therapeutics (US)
- Elanco Animal Health (US)
- Vetivax (US)
- Anivive Lifesciences (US)
- Regeneus (Australia)
- Qbiotics (Australia)
- Zoetis (US)
- VetDC (US)
- AB Science (France)
- Merial (France)
- VET Therapeutics (US)
- Vet Cancer Group (US)
- VetriScience (US)
- Vetnostics (Australia)
- Veterinary Cancer Group (US)
- PetCure Oncology (US)
- Veterinary Cancer Society (US)
- PetCure Oncology (US)
- Oasmia Pharmaceutical (Sweden)
Pet Cancer Therapeutics Market Recent Developments
- In July 2023, Boehringer Ingelheim International GmbH gained FDA approval for NexGard PLUS, a chewable tablet designed to protect dogs from internal and external parasites.
- In December 2022, Elanco Animal Health Inc. achieved FDA approval for Bexacat, a groundbreaking oral treatment for feline diabetes.
Global Pet Cancer Therapeutics Key Market Trends
- Rising Emphasis on Personalized Treatment: A significant trend in the global pet cancer therapeutics market is the increasing emphasis on personalized treatment approaches. Pet owners and veterinarians are recognizing the uniqueness of each pet's cancer diagnosis and treatment requirements. This trend is driving the demand for tailored therapeutic solutions, including precision medicine and targeted therapies. Advancements in diagnostics, such as genetic profiling and molecular testing, are enabling more precise cancer diagnoses. Consequently, treatment plans can be customized to the specific characteristics of a pet's cancer, improving treatment efficacy, and potentially reducing side effects. This shift towards personalized treatment reflects a growing commitment to enhancing the quality of care and outcomes for pets diagnosed with cancer.
Global Pet Cancer Therapeutics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to global pet cancer therapeutics market analysis, the market exhibits a multifaceted landscape characterized by a convergence of factors. A notable trend is the heightened awareness of pet health and the increasing demand for advanced cancer treatment options. Pet owners are increasingly seeking effective and compassionate care for their beloved animal companions, spurring innovation in the field. Veterinary oncology has made significant strides, facilitating precise diagnoses and targeted treatments. Furthermore, the integration of cutting-edge technologies, such as personalized medicine and immunotherapy, is reshaping the therapeutic landscape.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 273.91 million |
| Market size value in 2031 | USD 667.31 million |
| Growth Rate | 10.4% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Pet Cancer Therapeutics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Pet Cancer Therapeutics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Pet Cancer Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Pet Cancer Therapeutics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Pet Cancer Therapeutics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Pet Cancer Therapeutics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Pet Cancer Therapeutics Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
